Bank Pictet & Cie (Europe)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Sell
22,823
-3,936
-15% -$1.89M 0.22% 70
2026
Q1
$13.2M Sell
26,759
-8,054
-23% -$4.37M 0.28% 67
2025
Q4
$20.2M Sell
34,813
-1,381
-4% -$781K 0.4% 50
2025
Q3
$17.6M Sell
36,194
-3,510
-9% -$1.63M 0.35% 57
2025
Q2
$16.1M Sell
39,704
-38,275
-49% -$16M 0.34% 59
2025
Q1
$38.8M Sell
77,979
-75,178
-49% -$40.7M 0.93% 32
2024
Q4
$79.7M Buy
153,157
+461
+0.3% +$253K 1.75% 14
2024
Q3
$94.5M Buy
152,696
+1,657
+1% +$981K 2.23% 9
2024
Q2
$83.5M Buy
151,039
+17,430
+13% +$9.99M 2.03% 11
2024
Q1
$77.7M Buy
133,609
+12,370
+10% +$6.94M 2.02% 12
2023
Q4
$64.4M Buy
121,239
+4,908
+4% +$2.38M 1.91% 12
2023
Q3
$58.9M Sell
116,331
-395
-0.3% -$210K 2.05% 13
2023
Q2
$60.9M Sell
116,726
-20,074
-15% -$10.8M 2.07% 13
2023
Q1
$78.8M Sell
136,800
-10,433
-7% -$5.88M 3.28% 6
2022
Q4
$81.1M Sell
147,233
-3,986
-3% -$2.11M 3.96% 5
2022
Q3
$76.7M Sell
151,219
-178
-0.1% -$99.6K 3.78% 5
2022
Q2
$82.3M Sell
151,397
-1,629
-1% -$897K 3.8% 5
2022
Q1
$90.4M Buy
153,026
+6,198
+4% +$3.56M 3.47% 5
2021
Q4
$98M Buy
146,828
+24,916
+20% +$15.6M 3.34% 7
2021
Q3
$69.7M Sell
121,912
-982
-0.8% -$539K 2.58% 9
2021
Q2
$62M Buy
122,894
+34,878
+40% +$16.5M 2.16% 12
2021
Q1
$40.2M Buy
88,016
+11,951
+16% +$5.7M 1.61% 20
2020
Q4
$35.4M Sell
76,065
-8,729
-10% -$4.09M 1.74% 20
2020
Q3
$37.4M Buy
84,794
+11,283
+15% +$4.66M 2.1% 16
2020
Q2
$26.6M Sell
73,511
-5,002
-6% -$1.68M 1.86% 22
2020
Q1
$22.3M Buy
78,513
+10,918
+16% +$3.44M 2.02% 17
2019
Q4
$22M Buy
67,595
+5,813
+9% +$1.76M 3.23% 8
2019
Q3
$18M Buy
61,782
+572
+0.9% +$164K 3.07% 9
2019
Q2
$18M Buy
61,210
+6,814
+13% +$1.88M 3.1% 9
2019
Q1
$14.9M Sell
54,396
-7,963
-13% -$1.98M 2.54% 11
2018
Q4
$14M Sell
62,359
-6,606
-10% -$1.55M 2.85% 8
2018
Q3
$16.8M Buy
68,965
+6,379
+10% +$1.47M 2.37% 10
2018
Q2
$13M Sell
62,586
-7,629
-11% -$1.62M 2% 11
2018
Q1
$14.5M Buy
70,215
+7,696
+12% +$1.62M 2.4% 12
2017
Q4
$11.9M Sell
62,519
-10,657
-15% -$2.04M 1.68% 20
2017
Q3
$13.8M Sell
73,176
-5,184
-7% -$939K 1.99% 14
2017
Q2
$13.7M Sell
78,360
-9,643
-11% -$1.62M 1.93% 13
2017
Q1
$13.5M Buy
88,003
+1,550
+2% +$237K 1.94% 15
2016
Q4
$12.2M Sell
86,453
-1,858
-2% -$274K 2.04% 13
2016
Q3
$14M Sell
88,311
-41,058
-32% -$6.33M 2.58% 12
2016
Q2
$19.1M Sell
129,369
-30,033
-19% -$4.43M 3.97% 10
2016
Q1
$22.6M Buy
159,402
+5,865
+4% +$786K 4.51% 6
2015
Q4
$21.8M Buy
153,537
+6,115
+4% +$816K 4.3% 6
2015
Q3
$18M Buy
+147,422
New +$19.2M 4.18% 5
2015
Q2
Sell
-120,900
Closed -$16.2M 152
2015
Q1
$16.2M Buy
120,900
+43,115
+55% +$5.56M 3.89% 4
2014
Q4
$9.75M Buy
77,785
+11,830
+18% +$1.44M 2.49% 10
2014
Q3
$8.03M Buy
65,955
+50,615
+330% +$6.15M 2.17% 14
2014
Q2
$1.81M Buy
+15,340
New +$1.81M 0.56% 40

Other funds holding TMO

Bank Pictet & Cie (Europe)'s TMO Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $1.89M and leaving 22,823 shares worth $11.4M. The position accounts for 0.22% of the portfolio, ranked #70.

Bank Pictet & Cie (Europe) first reported a position in TMO in Q2 2014 and has held it in 48 quarters since. The position peaked at $98M in Q4 2021. 1,733 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 22,823 shares of Thermo Fisher Scientific worth $11.4M as of Q2 2026.
  • Bank Pictet & Cie (Europe) sold 3,936 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.89M.
  • Thermo Fisher Scientific made up 0.22% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #70 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 48 quarters since.
  • Bank Pictet & Cie (Europe)'s Thermo Fisher Scientific position peaked at $98M in Q4 2021.
  • 1,733 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.